Disorders of sex development;Störungen der Geschlechtsentwicklung

Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz

Volumn 50, Issue 12, 2007, Pages 1569-1577

  Thyen, U ^a   Hampel, E ^a   Hiort, Olaf ^a,b  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b Klinik fur Kinder und Jugendmedizin   (Germany)

Author keywords

Disorders of sex development; DSD; Endocrinology; Genetics

Indexed keywords

ARTICLE; CLINICAL PRACTICE; GENETIC PREDISPOSITION; GENETICS; GERMANY; HUMAN; PRACTICE GUIDELINE; SEX DIFFERENTIATION DISORDER;

GENETIC PREDISPOSITION TO DISEASE; GERMANY; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; SEX DIFFERENTIATION DISORDERS;

EID: 37149050837     PISSN: 14369990     EISSN: 14371588     Source Type: Journal    
DOI: 10.1007/s00103-007-0393-5     Document Type: Article

References (38)

1. Thyen U, Lanz K, Holterhus PM, Hiort O (2006) Epidemiology and initial management of ambiguous genitalia at birth in Germany. Horm Res 66:195-203
2. Brennan J, Capel B (2004) One tissue, two fates: molecular genetic events that underlie testis versus ovary development. Nat. Rev Genetics 5:509-521
3. Fleming A, Vilain E (2005) The endless quest for sex determination genes. Clin Genet 67:15-25
4. Cui S, Ross A, Stallings N, et al. (2004) Disrupted gonadogenesis and male-to-female sex reversal in Pod1 knockout mice. Development 131:4095-4105
5. Bardoni B, Zanaria E, Guioli S, et al. (1994) A dosage sensitive locus at chromosome Xp21 is involved in male to female sex reversal. Nat Genet 7:497-501
6. Colvin JS, Green RP, Schmahl J, et al. (2001) Maleto- female sex reversal in mice lacking fibroblast growth factor 9. Cell 104:875-889
7. Bennett CP, Docherty Z, Robbs SA, et al. (1993) Deletion 9p and sex reversal. J Med Genet 30:518-520
8. Meeks JJ, Weiss J, Jameson JL (2003) Dax1 is required for testis determination. Nat Genet 34:32-33
9. Röpke A, Pelz AF, Volleth M, et al. (2004) Sex chromosomal mosaicism in the gonads of patients with gonadal dysgenesis, but normal female or male karyotypes in lymphocytes. Am J Obstet Gynecol 190:1059-1062
10. Köhler B, Schumacher V, l'Allemand D, et al. (2001) Germline Wilms tumor suppressor gene (WT1) mutation leading to isolated genital malformation without Wilms tumor or nephropathy. J Pediatr 138:421-424
11. Köhler B, Pienkowski C, Audran F, et al. (2004) An N-terminal WT1 mutation (P181S) in an XY patient with ambiguous genitalia, normal testosterone production, absence of kidney disease and associated heart defect: enlarging the phenotypic spectrum of WT1 defects. Eur J Endocrinol 150:825-830
12. Hiort O, Holterhus PM (2000) The molecular basis of male sexual differentiation. Eur J Endocrinol 142:101-110. Review
13. Achermann JC, Ito M, Ito M, et al. (1999) A mutation in the gene encoding steroidogenic factor 1 causes XY sex reversal and adrenal failure in humans. Nat Genet 22:125-126
14. Koopman P, Gubbay J, Vivian N, et al. (1991) Male development of chromosomally female mice transgenic for Sry. Nature 351:117-121
15. MacLaughlin DT, Donahoe PK (2004) Sex determination and differentiation. N Engl J Med 350:367-378
16. Jordan BK, Mohammed M, Ching ST, et al. (2001) Up-Regulation of WNT-4 signaling and dosagesensitive sex reversal in humans. Am J Hum Genet 68:1102-1109
17. Hiort O, Holterhus PM (2004) Molecular and hormone dependent events in sexual differentiation. In Henry A, Norman A (eds): Encyclopedia of hormones. Academic Press, Los Angeles, pp 349-356
18. Richter-Unruh A, Martens JW, Verhoef-Post M, et al. (2002). Leydig cell hypoplasia: cases with new mutations, new polymorphisms and cases without mutations in the luteinizing hormone receptor gene. Clin Endocrinol 56:103-112
19. Latronico AC (2000) Naturally occurring mutations of the luteinizing hormone receptor gene affecting reproduction. Semin Reprod Med 18:17-20
20. Hiort O, Holterhus PM, Werner R, et al. (2005) Homozygous disruption of P450scc (CYP11A1) is associated with prematurity, complete 46,XY sex reversal and severe adrenal failure. J Clin Endocrinol Metab 90:538-541
21. Miller WL (1998) Why nobody has P450scc (20,22 desmoslase) deficiency. J Clin Endocrinol Metab 83:1399-1400
22. Pang S (2001) Congenital adrenal hyperplasia owing to 3 beta-hydroxysteroid dehydrogenase deficiency. Endocrinol Metab Clin North Am 30:81-99, vi-vii
23. Forest MG, Nicolino M, David M, Morel Y (2004) The virilized female: endocrine background. BJU Int 93(Suppl 3):35-43
24. Krone N, Riepe FG, Grötzinger J, et al. (2005) The residue E351 is essential for the activity of human 21-hydroxylase: evidence from a naturally occurring novel point mutation compared with artificial mutants generated by single amino acid substitutions. J Mol Med 83:561-568
25. Krone N, Riepe FG, Götze D, et al. (2005) Congenital adrenal hyperplasia (CAH) due to 11-hydroxylase deficiency: functional characterization of two novel point mutations and a three base pair deletion in the CYP11B1 gene. J Clin Endocrinol Metab 90:3724-3730
26. Riepe FG, Tatzel S, Sippell WG, et al. (2005) Congenital adrenal hyperplasia: the molecular basis of 21-hydroxylase deficiency in H-2(aw18) mice. Endocrinology 146:2563-2574
27. Prader A (1954) Genital findings in the female pseudo-hermaphroditism of the congenital adrenogenital syndrome; morphology, frequency, development and heredity of the different genital forms. Helv Paediatr Acta 9:231-248
28. Hiort O, Sinnecker GH, Holterhus PM, et al. (1996) The clinical and molecular spectrum of androgen insensitivity syndromes. Am J Med Genet 63:218-222
29. Hiort O, Sinnecker GH, Willenbring H, et al. (1996) Nonisotopic single strand conformation analysis of the 5 alpha-reductase type 2 gene for the diagnosis of 5 alpha-reductase deficiency. J Clin Endocrinol Metab 81:3415-3418
30. Twesten W, Holterhus P, Sippell W, et al. (2000) Clinical, endocrine, and molecular genetic findings in patients with 17β-hydroxysteroid dehydrogenase deficiency. Horm Res 53:26-31
31. Hiort O, Reinecke S, Thyen U, et al. (2003). Puberty in disorders of somatosexual differentiation. J Pediatr Endocrinol Metab 16(Suppl 2):297-306
32. Thiele S, Hoppe U, Holterhus PM, Hiort O (2005) Isoenzyme type 1 of 5alpha-reductase is abundantly transcribed in normal human genital skin fibroblasts and may play an important role in masculinization of 5alpha-reductase type 2 deficient males. Eur J Endocrinol 152:875-880
33. Hoppe U, Holterhus PM, Wunsch L, et al. (2006) Tissue-specific transcription profiles of sex steroid biosynthesis enzymes and the androgen receptor. J Mol Med 84:651-669
34. Werner R, Holterhus PM, Binder G, et al. (2006) The A645D Mutation in the hinge region of the human AR gene modulates AR activity depending on the context of the polymorphic glutamine and glycine repeats. J Clin Endocrinol Metab 91:3515-3520
35. Bebermeier JH, Brooks JD, Deprimo SE, et al. (2006) Cell-line and tissue-specific signatures of androgen receptor-coregulator transcription. J Mol Med 84:919-931
36. Werner R, Schutt J, Hannema S, et al. (2006) Androgen receptor gene mutations in androgen insensitivity syndrome cause distinct patterns of reduced activation of androgen-responsive promoter constructs. J Steroid Biochem Mol Biol 101:1-10
37. Hughes IA, Houk C, Ahmed SF, Lee PA & LWPES/ ESPE Consensus Group (2006) Consensus Statement on Management of Intersex Disorders. Arch Dis Child 14:37-45
38. Johannsen TH, Ripa CP, Mortensen EL, Main KM (2006) Quality of life in 70 women with disorders of sex development. Eur J Endocrinol 155:877-885